Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q3 2026, worth $43.6M in total; no superinvestor holds it.
Holders of 5% or more of MIST
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Milestone Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Propel Bio Management, LLC | 13G/A | 10.10%12.6M shares | +0.20 ppfrom 9.90% | Dec 23, 20252 filings | Nov 20, 2026 | SEC |
| RTW Investments, LP | 13G/A | 9.90%12.4M shares | 0.00 ppfrom 9.90% | Feb 12, 20216 filings | May 15, 2026 | SEC |
| Pavaki Capital Management LLC | 13G | 7.30%9.07M shares | New | Aug 7, 20261 filing | Aug 7, 2026 | SEC |
| Adage Capital Management, L.P. | 13G/A | 6.37%8.00M shares | −3.62 ppfrom 9.99% | Nov 13, 20252 filings | May 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
48 Schedule 13D and 13G filings on Milestone Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 20, 20261:27 PM ET | Propel Bio Management, LLCand 3 others | 13G/A | 10.10%12.6M shares | +0.20 ppfrom 9.90% | Nov 19, 2026 | SEC |
| Aug 7, 20261:49 PM ET | Pavaki Capital Management LLCand 2 others | 13G | 7.30%9.07M shares | New | Dec 31, 2025 | SEC |
| May 15, 20268:26 AM ET | RTW Investments, LPand 1 other | 13G/A | 9.90%12.4M shares | 0.00 ppfrom 9.90% | Mar 31, 2026 | SEC |
| May 13, 20269:09 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 6.37%8.00M shares | −3.62 ppfrom 9.99% | Mar 31, 2026 | SEC |
| Mar 26, 20265:37 PM ET | Trails Edge Capital Partners, LPand 2 others | 13G/A | 4.30%5.33M shares | −5.60 ppfrom 9.90%Below 5% | Mar 20, 2026 | SEC |
| Dec 23, 20252:20 PM ET | Propel Bio Management, LLCand 3 others | 13G | 9.90%8.86M shares | New | Jul 11, 2025 | SEC |
| Nov 14, 20254:05 PM ET | Trails Edge Capital Partners, LPand 2 others | 13G/A | 9.90%9.02M shares | 0.00 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Nov 14, 20258:30 AM ET | RTW Investments, LPand 1 other | 13G/A | 9.90%9.16M shares | −0.09 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Nov 13, 20259:10 AM ET | Adage Capital Management, L.P.and 2 others | 13G | 9.99%8.66M shares | New | Sep 30, 2025 | SEC |
| Jul 21, 20254:30 PM ET | Trails Edge Capital Partners, LPand 2 others | 13G | 9.90%8.85M shares | New | Jul 14, 2025 | SEC |
| Apr 30, 20254:00 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G/A | 0.60%322.1K shares | –Below 5% | Mar 31, 2025 | SEC |
| Apr 22, 20259:32 AM ET | BlackRock, Inc. | 13G/A | 0.00%0 shares | −7.60 ppfrom 7.60%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20259:00 AM ET | RTW Investments, LPand 1 other | 13G/A | 9.99%5.64M shares | – | Dec 31, 2024 | SEC |
| Feb 5, 20251:23 PM ET | BlackRock, Inc. | 13G/A | 7.60%4.05M shares | – | Dec 31, 2024 | SEC |
| Oct 29, 2024 | Integrated Core Strategies (US) LLC | 13G/AOld format | – | – | – | SEC |
| Jul 16, 2024 | Alta Fundamental Advisers LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 20247:41 PM ET | Goldman Sachs Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 29, 2024 | Integrated Core Strategies (US) LLC | 13G/AOld format | – | – | – | SEC |
| Jan 24, 20242:27 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 9, 2023 | Alta Fundamental Advisers LLC | 13DOld format | – | New | – | SEC |
| Feb 14, 2023 | Ikarian Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | OrbiMed Capital LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Boxer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 20239:06 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 19, 20239:19 AM ET | Goldman Sachs Group Inc | 13GOld format | – | New | – | SEC |
| Jan 18, 2023 | Integrated Core Strategies (US) LLC | 13G/AOld format | – | – | – | SEC |
| Oct 31, 2022 | Integrated Core Strategies (US) LLC | 13GOld format | – | New | – | SEC |
| Oct 24, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Sep 26, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Sep 20, 2022 | Venrock Healthcare Capital Partners III, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Boxer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Ikarian Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | OrbiMed Capital LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Boxer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Forbion Capital Fund III Cooperatief U.A. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Fonds de Solidarite des Travailleurs du Quebec | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | OrbiMed Capital LLC | 13GOld format | – | New | – | SEC |
| Jan 21, 2021 | Domain Partners VIII, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 11, 2021 | Ikarian Capital, LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
3 notices from officers, directors and other affiliates planning to sell Milestone Pharmaceuticals Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Apr 16, 20264:12 PM ET | Joseph OlivetoDirector · Officer | 36.5K | $80.3K | Apr 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 8, 20264:25 PM ET | Joseph OlivetoDirector · Officer | 79.5K | $170.9K | Jan 8, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 7, 20264:22 PM ET | Joseph OlivetoOfficer | 500 | $1.02K | Jan 7, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |